Urinary Disorders and Female Sexual Function

Abstract

Overactive bladder urinary incontinence and female sexual dysfunction are common in women, but often go unreported and/or untreated. All of these conditions can have a markedly negative impact on quality of life. There is a growing body of evidence that sexual and urinary problems are often comorbid and possibly synergistic in women. Increasingly robust evidence indicates that management of urinary concerns may enhance sexual function and quality of life. It is important for health care providers who see women to consider both urinary and sexual health concerns during patient encounters. Additional research attention to the interrelationships between these genitourinary disorders is warranted.

Vejiga Hiperactiva y Calidad de Vida

“…But, the biggest problem in the sexual activity of women with OAB is the leakage during coitus. Coital incontinence in women with stress urinary incontinence is usually related to penetration, whereas women diagnosed with OAB experience incontinence during orgasm (Chen, Sweet, & Shindel, 2013;Ergenoglu, et al, 2013;Serati, et al, 2008) Also, it should be stand out nocturia in patients with OAB. International Continente Society (ICS) defines nocturia when the person complains that wakes up at night one or more times to urinate.…”

Which are the male factors associated with female sexual dysfunction (FSD)?

“…Finally, in our sample of subjects consulting for FSD, overall sexual functioning was negatively associated with just a few organic parameters, such as menopause, history of genitourinary disorders, and surgical procedures (in particular, pelvic surgery); interestingly, these factors along with anatomical damage (Stellman, 1990;Vardi, 2006;Chen et al, 2013), are likely to have a detrimental effect also on the sense of integrity and femininity (Stellman, 1990). When metabolic parameters or cardiovascular risk factors were evaluated, we were not able to observe any significant correlation with FSFI total score, corroborating the concept that female sexual function, differently from men, is not a harbinger of cardiovascular diseases (Miner et al, 2012).…”

Vaistų, Vartojamų Dirgliosios Šlapimo Pūslės Sindromo Gydymui, Efektyvumo Palyginimas

“…ICS -International Continence Society) apibrėžia dirgliąją šlapimo pūslę (DŠP) kaip staiga pasireiškiantį nenumaldomą norą šlapintis su arba be šlapimo nelaikymo (ŠN), neretai lydimą dažno šlapinimosi dienos ir nakties metu [6]. Nors tyrimais patvirtinta, jog ši patologija turi neigiamą įtaką moterų kasdieninei veiklai bei su sveikata susijusiai gyvenimo kokybei, daugelis moterų nepamini simptomų gydytojui, kadangi jaučiasi nejaukiai, bei mano, jog dirgliosios šlapimo pūslės požymiai yra normali jų amžiaus bei buvusių gimdymų pasekmė [7][8][9][10][11][12]. Anticholinerginiai vaistai laikomi pirmo pasirinkimo medikamentiniu gydymu kontroliuoti DŠP simptomams [13].…”